Investigators: Euphrosyne Gouzoulis-Mayfrank, MD et al. Aachen, Germany Contact: Euphrosyne Gouzoulis-Mayfrank, MD Sponsor: DFG (Deutsche Forschungsgemeinschaft = German Research Foundation) Human research …
Investigators: Karen Bolla, PhD et al. Johns Hopkins University – Baltimore, Maryland Sponsor: NIH Neuropsychological memory testing of MDMA users and controls. Also see Alex Gamma – MDMA and …
Investigator: Rudolf Brenneisen, PhD University of Bern, Switzerland Contact: br> Completed and published, just a few subjects. Also see the details and references section.
Investigators: Una McCann, MD, George Ricaurte, MD, PhD Johns Hopkins University – Baltimore, Maryland Sponsor:NIH PET scan study, MDMA Neurotoxicity, MDMA Users vs. Control Group. MAPS Commentary …
Investigator: Manfred Spitzer, MD, PhD et al. Psychiatrische Universitats Klinic, Heidelberg, Germany Human clinical study, completed and published. More psilocybin research in Germany Spitzer M, et al. …
Human Psychedelic Research: A Historical And Sociological Analysis Undergraduate Thesis for the Degree of Bachelor of Arts in Natural Sciences (History and Philosophy of Science) by Luke Williams, April …
You can read this report in its original form here. MAPS IRS Form 990 for 1998 in PDF format Fiscal Year June 1, 1997 — May 31, 1998 (FY 97-98) was a strong year for MAPS with a combination of important …
In this section of the Rites of Passage project, families share their experiences creating their own contexts for psychedelics and marijuana. Just as each family is unique, each of the following accounts …
This past fiscal year, which ran from June 1, 1995 to May 31, 1996, was MAPS' tenth and most successful ever in terms of both fund-raising and membership. I believe that at least part of this increasing …
Investigator: Manfred Spitzer, MD, PhD et al. Psychiatrische Universitats Klinic, Heidelberg, Germany Human clinical study, completed and published. More psilocybin research in Germany Spitzer M, et al. …
[This is not the current version of this protocol] Version 4.1 August 22, 1995 A DOSE/RESPONSE HUMAN PILOT STUDY – SAFETY AND EFFICACY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) IN MODIFICATION OF PHYSICAL …
You can read this report in its original form here. Total Income for FY 93-94 was $106,650.48. There you have it, MAPS' financial report for FY 93-94. MAPS continues to grow as does its research agenda, …
